MedTrace Logo

Pharmacodynamic and Safety of MBA-P01 in Healthy Male Volunteers

NCT03547141 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2019-03-26

No results posted yet for this study

Summary

To determine the pharmacodynamic and safety of MBA-P01 in Healthy Male Volunteers

Conditions

  • Healthy

Interventions

DRUG

MBA-P01

injection of MBA-P01 into the muscle of each contralateral foot in equal doses

DRUG

BOTOX

injection of BOTOX into the muscle of each contralateral foot in equal doses

Sponsors & Collaborators

  • Medy-Tox

    lead INDUSTRY

Principal Investigators

  • Myungeun Chung · The Catholic University, St. Paul's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-16
Primary Completion
2018-08-28
Completion
2018-11-01

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03547141 on ClinicalTrials.gov